Cipla
RAHUL VERMA has extensive experience in corporate finance and taxation, currently serving as Vice President of Corporate Finance at Cipla. Previously, RAHUL held the position of Head of Finance and Taxation at Apollo Tyres Ltd and served as General Manager at both Intex Technologies (India) Ltd. and Coforge. Additionally, RAHUL was a Partner at a Delhi-based CA Firm affiliated with RSM International Network and GMN International, which are recognized among the largest global networks.
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.